NR4A1 and neoplasm: These data show that some of the cohort characteristics such as the mean age at diagnosis, the percentage of node positive patients, the grade and tumor type distributions, and the rate of positive hormone receptors are consistent with the European breast cancer population characteristics [19, 20].